HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹367 Cr | ₹423 Cr | ₹490 Cr | ₹287 Cr | ₹263 Cr |
What is the latest Secured Loans ratio of HIKAL ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹423 Cr |
| Mar2023 | ₹490 Cr |
| Mar2022 | ₹287 Cr |
| Mar2021 | ₹263 Cr |
How is Secured Loans of HIKAL Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -13.17 | |
| Mar2024 | ₹423 Cr | -13.67 | |
| Mar2023 | ₹490 Cr | 70.88 | |
| Mar2022 | ₹287 Cr | 9.05 | |
| Mar2021 | ₹263 Cr | - | |
Compare Secured Loans of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,618.3 Cr | -2.3% | -2.2% | -16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.3% |
-2.2% |
-16.1% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses